299 related articles for article (PubMed ID: 21848863)
1. Thrombosis of tunneled-cuffed hemodialysis catheters: treatment with high-dose urokinase lock therapy.
Donati G; Colì L; Cianciolo G; La Manna G; Cuna V; Montanari M; Gozzetti F; Stefoni S
Artif Organs; 2012 Jan; 36(1):21-8. PubMed ID: 21848863
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters (TCC) thrombosis.
Colì L; Donati G; Cianciolo G; Raimondi C; Comai G; Panicali L; Nastasi V; Cannarile DC; Gozzetti F; Piccari M; Stefoni S
J Vasc Access; 2006; 7(3):118-22. PubMed ID: 17019663
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters.
Mokrzycki MH; Jean-Jerome K; Rush H; Zdunek MP; Rosenberg SO
Kidney Int; 2001 May; 59(5):1935-42. PubMed ID: 11318966
[TBL] [Abstract][Full Text] [Related]
4. Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial.
Saxena AK; Panhotra BR; Sundaram DS; Morsy MN; Al-Ghamdi AM
Nephrology (Carlton); 2006 Aug; 11(4):299-305. PubMed ID: 16889569
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of urokinase lock to treat thrombotic dysfunction of tunneled hemodialysis catheters: A retrospective cohort study.
Van Hulle F; Bonkain F; De Clerck D; Aerden D; Vanwijn I; Tielemans C; Wissing KM
J Vasc Access; 2019 Jan; 20(1):60-69. PubMed ID: 29893163
[TBL] [Abstract][Full Text] [Related]
6. Urokinase-containing locking solution in the prevention of dialysis catheter dysfunction: a double blind randomized controlled trial.
Bonkain F; Van Hulle F; Janssens P; Catalano C; Allamani M; Stolear JC; Vandervelde D; Libertalis M; Treille S; Couttenye MM; Dhondt A; Van Biesen W; Fils JF; Tielemans C; Wissing KM
J Vasc Access; 2017 Sep; 18(5):436-442. PubMed ID: 28623638
[TBL] [Abstract][Full Text] [Related]
7. Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using vancomycin and gentamycin.
Al-Hwiesh AK; Abdul-Rahman IS
Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):239-47. PubMed ID: 17496402
[TBL] [Abstract][Full Text] [Related]
8. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study.
Saxena AK; Panhotra BR
J Nephrol; 2005; 18(6):755-63. PubMed ID: 16358235
[TBL] [Abstract][Full Text] [Related]
9. [Tesio twin catheter system for hemodialysis tunnelized using an echo-guided technique. Retrospective analysis of 210 catheters].
Ibrik O; Samon R; Roca R; Viladoms J; Mora J
Nefrologia; 2006; 26(6):719-25. PubMed ID: 17227250
[TBL] [Abstract][Full Text] [Related]
10. Diabetes decreases patency of tunneled catheters in hemodialysis patients after first effective thrombolysis with urokinase.
Wójtowicz D; Cholewa D; Faba AM; Domańska B; Kokoszka J; Kopacz K; Ficek R; Irzyniec T; Rotkegel SE; Chudek J
Ren Fail; 2018 Nov; 40(1):384-389. PubMed ID: 30010473
[TBL] [Abstract][Full Text] [Related]
11. Tunneled catheter-antibiotic lock therapy for prevention of dialysis catheter-related infections: a single center experience.
Al-Hwiesh AK
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):593-602. PubMed ID: 18580019
[TBL] [Abstract][Full Text] [Related]
12. Chronic and acute consequences of a post-dialysis urokinase lock on permanent hemodialysis catheter function.
Gabutti L; Mosconi E; Pellegrini L; Duchini F; Marone C
J Nephrol; 2006; 19(2):183-8. PubMed ID: 16736417
[TBL] [Abstract][Full Text] [Related]
13. Locking tunneled hemodialysis catheters with hypertonic saline (26% NaCl) and heparin to prevent catheter-related bloodstream infections and thrombosis: a randomized, prospective trial.
Oguzhan N; Pala C; Sipahioglu MH; Cilan H; Durmaz S; Percin D; Unal A; Tokgoz B; Utas C; Oymak O
Ren Fail; 2012; 34(2):181-8. PubMed ID: 22260745
[TBL] [Abstract][Full Text] [Related]
14. [Catheter lock solution--taurolock for prevention of catheter-related bacteremia in hemodialysis patients].
Geron R; Tanchilevski O; Kristal B
Harefuah; 2006 Dec; 145(12):881-4, 943. PubMed ID: 17220025
[TBL] [Abstract][Full Text] [Related]
15. A longitudinal study of the repeated use of alteplase as therapy for tunneled hemodialysis catheter dysfunction.
Little MA; Walshe JJ
Am J Kidney Dis; 2002 Jan; 39(1):86-91. PubMed ID: 11774106
[TBL] [Abstract][Full Text] [Related]
16. Does warfarin safely prevent clotting of hemodialysis catheters? a review of efficacy and safety.
Willms L; Vercaigne LM
Semin Dial; 2008; 21(1):71-7. PubMed ID: 18251961
[TBL] [Abstract][Full Text] [Related]
17. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D
Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
[TBL] [Abstract][Full Text] [Related]
18. A phase III, randomized, double-blind, placebo-controlled study of tenecteplase for improvement of hemodialysis catheter function: TROPICS 3.
Tumlin J; Goldman J; Spiegel DM; Roer D; Ntoso KA; Blaney M; Jacobs J; Gillespie BS; Begelman SM
Clin J Am Soc Nephrol; 2010 Apr; 5(4):631-6. PubMed ID: 20133491
[TBL] [Abstract][Full Text] [Related]
19. Systemic anticoagulation and prevention of hemodialysis catheter malfunction.
Zellweger M; Bouchard J; Raymond-Carrier S; Laforest-Renald A; Quérin S; Madore F
ASAIO J; 2005; 51(4):360-5. PubMed ID: 16156299
[TBL] [Abstract][Full Text] [Related]
20. Catheter lock heparin concentration: effects on tissue plasminogen activator use in tunneled cuffed catheters.
Holley JL; Bailey S
Hemodial Int; 2007 Jan; 11(1):96-8. PubMed ID: 17257362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
